Table Of Content

Clinica Chimica Acta 285 (1999) 201-203 Author index Volume 285 (1999) Altenbuchner, J., see Raimundo, S. 285, 155 Falkous, G., see Mantle, D. 285, 13 Aono, K., see Shimizu, H. 285, 169 Argente, J., see Calero, J.A. 285, 121 Garcia-Moreno, C., see Calero, J.A. 285, 121 Asada, H., see Shimizu, H. 285, 169 Ghalaut, P.S., see Singh Ghalaut, V. 285, 85 Giardina, B., see Gozzo, M.L. 285, 53 Barbaresi, G., see Gozzo, M.L. 285, 53 Giray, J., see Raimundo, S. 285, 155 Barragan-Gonzalez, E., see Lopez-Guerrero, J.A. Gozzo, M.L., Colacicco, L., Calla, C., Barbaresi, 285, 105 G., Parroni, R., Giardina, B., Lippa, S., De- Bideau, R., see Cao, (.Z. 285, 191 termination of copper, zinc, and selenium in Bolufer-Gilabert, P., see Lopez-Guerrero, J.A. human plasma and urine samples by poten- 285, 105 tiometric stripping analysis and constant current Bujo, H., see Kobayashi, J. 285, 173 stripping analysis 285, 53 Byrne, D.J., Neil, H.A.W., Vallance, D.T., Winder, Gylling, H., see Lindbohm, N. 285, 69 A.F., A pilot study of garlic consumption shows no significant effect on markers of oxidation or Hayakawa, T., see Okumura, K. 285, 91 sub-fraction composition of low-density lipopro- Higashino, K., see Shibutani, Y. 285, 183 tein including lipoprotein(a) after allowance for Hikita, M., see Kobayashi, J. 285, 173 non-compliance and the placebo effect 285, 21 Ikeda, Y., see Takagi, A. 285, 143 Calero, J.A., Munoz, M.T., Argente, J., Traba, Inouye, M., Mio, T., Sumino, K., Link between M.L., Méndez-Davila, C., Garcia-Moreno, C., de glycation and lipoxidation in red blood cells in la Piedra, C., A variation in Bone Alkaline diabetes 285, 35 Phosphatase levels that correlates positively with bone loss and normal levels of aminoterminal Kaneko, S., see Okumura, K. 285, 91 propeptide of collagen I in girls with anorexia Kasuga, Y., see Maruyama, M. 285, 131 nervosa 285, 121 Kato, R., see Maruyama, M. 285, 131 Calla, C., see Gozzo, M.L. 285, 53 Kawakami, K., see Okumura, K. 285, 91 Cao, (.Z., Bideau, R., Valdes, R., Elin, R.J., Acute Kharb, S., see Singh Ghalaut, V. 285, 85 hypermagnesemia and respiratory arrest follow- Kobayashi, J., Nagashima, |., Taira, K., Hikita, M., ing infusion of MgSO, for tocolysis 285, 191 Tamura, K., Bujo, H., Morisaki, N., Saito, Y., A Casal, J.A., see Pérez, L.F. 285, 45 novel frameshift mutation in exon 6 (the site of Chen, W.-Y., see Yang, C.-S. 285, 163 Asn 291) of the lipoprotein lipase gene in type I Colacicco, L., see Gozzo, M.L. 285, 53 hyperlipidemia 285, 173 Kobayashi, S., see Maruyama, M. 285, 131 de la Piedra, C., see Calero, J.A. 285, 121 Kuo, J.-S., see Yang, C.-S. 285, 163 Elin, R.J., see Cao, (.Z. 285, 191 Lindbohm, N., Gylling, H., Miettinen, T.E., Miet- PII: S009-8981(99)00131-X 202 Author index vol. 285 (1999) tinen, T.A., Sialic acid content of LDL and Qanungo, S., Sen, A., Mukherjea, M., Antioxidant lipoprotein metabolism in combined hyper- status and lipid peroxidation in human feto- lipidemia and primary moderate hypercholes- placental unit 285, | terolemia 285, 69 Lippa, S., see Gozzo, M.L. 285, 53 Raimundo, S., Giray, J., Volff, J.-N., Schwab, M., Liu, Z., Wang, W., Wei, M., LD-IgG, IgA, IgM Altenbuchner, J., Ratge, D., Wisser, H., Cloning complex in a postburn patient 285, 195 and sequence of partial cDNAs encoding the Lépez-Guerrero, J.A., Bolufer-Gilabert, P., Vera- human type V and VI adenylyl cyclases and Sempere, F.J., Marugan de la Concha, I., Barra- subsequent RNA-quantification in various gan-Gonzalez, E., C-erbB-2 expression and its tissues” 285, 155 relationship with ploidy, p53 abnormalities and Ratge, D., see Raimundo, S. 285, 155 epidermal growth factor receptor content in Rawal, A., see Singh Ghalaut,V. 285, 85 human non-small cell lung cancer 285, 105 Ribeiro, H.M., see Pérez, L.F. 285, 45 Mantle, D., Falkous, G., Perry, E.K., Effect of Sa Miranda, M.C., see Pérez, L.F. 285, 45 flavonoids on protease activities in human Saito, Y., see Kobayashi, J. 285, 173 skeletal muscle tissue in vitro 285, 13 Schwab, M., see Raimundo, S. 285, 155 Marugan de la Concha, I., see Lopez-Guerrero, J.A. Sen, A., see Qanungo, S. 285, | 285, 105 Shibutani, Y., Ueo, T., Yamamoto, T., Takahashi, Maruyama, M., Kato, R., Kobayashi, S., Kasuga, S., Moriwaki, Y., Higashino, K.. A case of Y., The detection of a unique antigen associated classical xanthinuria (type 1) with diabetes with papillary thyroid carcinoma 285, 131 mellitus and Hashimoto's thyroiditis 285, 183 Masuta, K., see Shimizu, H. 285, 169 Shimizu, H., Aono, K., Masuta, K., Asada, H., Matsui, H., see Okumura, K. 285, 91 Misaki, A., Teraoka, H., Stability of brain Méndez-Davila, C., see Calero, J.A. 285, 121 natriuretic peptide (BNP) in human blood sam- Miettinen, T.A., see Lindbohm, N. 285, 69 ples 285, 169 Miettinen, T.E., see Lindbohm, N. 285, 69 Shinozuka, T., see Takagi, A. 285, 143 Mio, T., see Inouye, M. 285, 35 Singh Ghalaut, V., Kharb, S., Ghalaut, P.S., Rawal, Misaki, A., see Shimizu, H. 285, 169 A., Lymphocyte glutathione levels in acute Mokuno, S., see Okumura, K. 285, 91 leukemia 285, 85 Morisaki, N., see Kobayashi, J. 285, 173 Sumino, K., see Inouye, M. 285, 35 Morishima, L., see Okumura, K. 285, 91 Moriwaki, Y., see Shibutani, Y. 285, 183 Tachi, K., see Takagi, A. 285, 143 Mukherjea, M., see Qanungo, S. 285, | Taira, K., see Kobayashi, J. 285, 173 Munoz, M.T., see Calero, J.A. 285, 121 Takagi, A., Ikeda, Y., Tachi, K., Shinozuka, T., Yamamoto, A., Identification of compound het- Nagashima, I., see Kobayashi, J. 285, 173 erozygous mutations (GI88E/W382X) of Neil, H.AW., see Byrne, DJ. 285, 21 lipoprotein lipase gene in a Japanese infant with Numaguchi, Y., see Okumura, K. 285, 91 hyperchylomicronemia. the G188E mutation was newly identified in Japanese 285, 143 Okumura, K., Matsui, H., Kawakami, K., Takahashi, S., see Shibutani, Y. 285, 183 Numaguchi, Y., Kaneko, S., Morishima, L., Tamura, K., see Kobayashi, J. 285, 173 Mokuno, S., Toki, Y., Hayakawa, T., Relation- Teraoka, H., see Shimizu, H. 285, 169 ship between the apolipoprotein E and angioten- Toki, Y., see Okumura, K. 285, 91 sin-converting enzyme genotypes and LDL par- Traba, M.L., see Calero, J.A. 285, 121 ticle size in Japanese subjects 285, 91 Tsai, P.-J., see Yang, C.-S. 285, 163 Tutor, J.C., see Pérez, L.F. 285, 45 Parroni, R., see Gozzo, M.L. 285, 53 Pérez, L.F., Ribeiro, H.M., Casal, J.A., Pinto, R.A., Ueo, T., see Shibutani, Y. 285, 183 Sa Miranda, M.C., Tutor, J.C., Thermodynamic characterisation of the mutated isoenzyme A of Valdes, R., see Cao, (.Z. 285, 191 B-N-acetylhexosaminidase in GM?2-gan- Vallance, D.T., see Byrne, DJ. 285, 21 gliosidosis B| variant 285, 45 Vera-Sempere, F.J., see L6pez-Guerrero, Perry, E.K., see Mantle, D. 285, 13 285, 105 Pinto, R.A., see Pérez, L.F. 285, 45 Volff, J.-N., see Raimundo, S. 285, 155 Author index vol. 285 (1999) 203 Wang, W., see Liu, Z. 285, 195 Yang, C.-S., Chen, W.-Y., Tsai, P.-J., Kuo, J.-S., Wei, M., see Liu, Z. 285, 195 a-Tocopherol acetate significantly suppressed Winder, A.F., see Byrne, DJ. 285, 21 the increase in heart interstitial 8-hydroxy- Wisser, H., see Raimundo, S. 285, 155 deoxyguanosine following myocardial ischemia and reperfusion in anesthetized rats 285, 163 Yamamoto, A., see Takagi, A. 285, 143 Yamamoto, T., see Shibutani, Y. 285, 183 ELSEVIER Clinica Chimica Acta 285 (1999) 205-207 Subject index Volume 285 (1999) Activation energy; GM2-gangliosidosis Bl var- Asn 291; Lipoprotein lipase; Type I hyperlipidemia iant; Mutated B-N-acetylhexosaminidase A 285, 285, 173 45 Bone alkaline phosphatase; Anorexia nervosa; Acute lymphocytic leukemia; Acute myeloid Bone formation markers; Procollagen amino- leukemia; Glutathione; Lymphocytes 285, 85 terminal propeptide 285, 121 Acute myeloid leukemia; Acute lymphocytic Bone formation markers, Anorexia nervosa; Bone leukemia; Glutathione; Lymphocytes 285, 85 alkaline phosphatase; Procollagen aminoterminal propeptide 285, 121 Adenylyl cyclases V and VI; Human heart; Partial cDNA sequence; Quantitative RT-PCR 285, Brain natriuretic peptide (BNP); Immuno- 155 radiometric assay (IRMA); Heart failure 285, 169 Allium sativum, Garlic; Antioxidants; Low-density lipoprotein; Lipoprotein(a) 285, 21 Brush border membrane; Placenta; Umbilical cord blood; Antioxidants; Lipid peroxidation Allopurinol; Classical xanthinuria; Diabetes mel- 285, | litus; Hashimoto's thyroiditis; Pyrazinamide 285, 183 3-cholesten-6-one, Diabetes mellitus; Erythrocyte membrane; Hemoglobin Alc 285, 35 Angiotensin-converting enzyme; Apolipoprotein E; LDL particle size; Genotype; Japanese 285, 91 Classical xanthinuria; Diabetes mellitus; Hashimoto’s thyroiditis; Allopurinol; Pyrazin- Anorexia nervosa; Bone formation markers; Bone amide 285, 183 alkaline phosphatase; Procollagen aminoterminal propeptide 285, 121 Combined hyperlipidemia; Sialic acid; Hyper- cholesterolemia; LDL kinetics 285, 69 Antioxidants; Garlic; Low-density lipoprotein; Lipoprotein(a); Allium sativum 285, 21 Compound heterozygous mutation; Lipoprotein lipase deficiency; Hyperchylomicronemia; Type I Antioxidants; Placenta; Brush border membrane; hyperlipoproteinemia; Hypertriglyceridemia; Umbilical cord blood; Lipid peroxidation 285, | Markit-F LPL 285, 143 Apolipoprotein E; Angiotensin-converting en- Constant current stripping analysis; Copper; zyme; LDL particle size; Genotype; Japanese Zinc; Selenium; Potentiometric stripping analysis 285, 91 285, 53 PII: $009-8981(99)00132-1 206 Subject index vol. 285 (1999) Copper; Zinc; Selenium; Potentiometric stripping Human heart; Adenylyl cyclases V and VI; Partial analysis; Constant current stripping analysis cDNA sequence; Quantitative RT-PCR 285, 285, 53 155 Diabetes mellitus; Classical xanthinuria; 8-Hydroxydeoxyguanosine; Myocardial ischemia/ Hashimoto’s thyroiditis; Allopurinol; Pyrazin- reperfusion; Microdialysis; High-performance amide 285, 183 liquid chromatography 285, 163 Diabetes mellitus; Erythrocyte membrane; 3- Hypercholesterolemia; Sialic acid; Combined hy- cholesten-6-one; Hemoglobin Alc 285, 35 perlipidemia; LDL kinetics 285, 69 Epidermal growth factor receptor; Non-small Hyperchylomicronemia; Lipoprotein lipase de- cell lung cancer; c-erbB-2 Expression; p53 Muta- ficiency; Compound heterozygous mutation; tions; Flow cytometry; p53 Overexpression; Re- Type I hyperlipoproteinemia; Hypertriglycerid- currence 285, 105 emia; Markit-F LPL 285, 143 c-erbB-2 Expression; Non-small cell lung cancer; Hypermagnesemia; Intoxication; Respiratory ar- p53 Mutations; Flow cytometry; p53 Overex- rest; Tocolysis 285, 191 pression; Epidermal growth factor receptor; Re- currence 285, 105 Hypertriglyceridemia; Lipoprotein lipase deficiency; Hyperchylomicronemia; Compound Erythrocyte membrane; Diabetes mellitus; 3- cholesten-6-one; Hemoglobin Alc 285, 35 heterozygous mutation; Type I hyperlipoproteinemia; Markit-F LPL 285, 143 Flavonoids; Proteases; Muscle 285, 13 Immunoradiometric assay (IRMA); Brain nat- Flow cytometry; Non-small cell lung cancer; c- riuretic peptide (BNP); Heart failure 285, 169 erbB-2 Expression; p53 Mutations; p53 Over- expression; Epidermal growth factor receptor; Intoxication; Hypermagnesemia; Respiratory ar- Recurrence 285, 105 rest; Tocolysis 285, 191 GM2-gangliosidosis B1 variant; Mutated B-N- Japanese, Apolipoprotein E; Angiotensin-convert- acetylhexosaminidase A; Activation energy ing enzyme; LDL particle size; Genotype 285, 285, 45 91 Garlic; Antioxidants; Low-density lipoprotein; LD-Ig complex; Postburn 285, 195 Lipoprotein(a); Allium sativum 285, 21 LDL kinetics; Sialic acid; Hypercholesterolemia; Genotype; Apolipoprotein E; Angiotensin-convert- Combined hyperlipidemia 285, 69 ing enzyme; LDL particle size; Japanese 285, 91 LDL particle size; Apolipoprotein E; Angiotensin- converting enzyme; Genotype; Japanese 285, 91 Glutathione; Acute myeloid leukemia; Acute lymphocytic leukemia; Lymphocytes 285, 85 Lipid peroxidation; Placenta; Brush border membrane; Umbilical cord blood; Antioxidants 285, Hashimoto’s thyroiditis; Classical xanthinuria; Diabetes mellitus; Allopurinol; Pyrazinamide l 285, 183 Lipoprotein lipase; Type | hyperlipidemia; Asn Heart failure; Brain natriuretic peptide (BNP); 291 285, 173 Immunoradiometric assay (IRMA) 285, 169 Lipoprotein lipase deficiency; Hyperchylomicro- Hemoglobin Alc; Diabetes mellitus; Erythrocyte nemia; Compound heterozygous mutation; Type membrane; 3-cholesten-6-one 285, 35 I hyperlipoproteinemia; Hypertriglyceridemia; Markit-F LPL 285, 143 High-performance liquid chromatography: Myocardial ischemia/reperfusion; 8-Hydroxy- Lipoprotein(a); Garlic; Antioxidants; Low-density deoxyguanosine; Microdialysis 285, 163 lipoprotein; Allium sativum 285, 21 Subject index vol. 285 (1999) «2' 07 Low-density lipoprotein; Garlic; Antioxidants; Procollagen aminoterminal propeptide; Anorexia Lipoprotein(a); Allium sativum 285, 21 nervosa; Bone formation markers; Bone alkaline phosphatase 285, 121 Lymphocytes; Acute myeloid leukemia; Acute lymphocytic leukemia; Glutathione 285, 85 Proteases; Flavonoids; Muscle 285, 13 Markit-F LPL; Lipoprotein lipase deficiency; Hy- Pyrazinamide; Classical xanthinuria; Diabetes perchylomicronemia; Compound heterozygous mellitus; Hashimoto’s thyroiditis; Allopurinol mutation; Type I hyperlipoproteinemia; Hypertri- 285, 183 glyceridemia 285, 143 Quantitative RT-PCR; Adenylyl cyclases V and Microdialysis; Myocardial ischemia/reperfusion; VI; Human heart; Partial cDNA sequence 285, 8-Hydroxydeoxyguanosine; High-performance 155 liquid chromatography 285, 163 Recurrence; Non-small cell lung cancer; c-erbB-2 Muscle; Flavonoids; Proteases 285, 13 Expression; p53 Mutations; Flow cytometry; p53 Overexpression; Epidermal growth factor recep- Mutated B-N-acetylhexosaminidase A; GM2-gan- tor 285, 105 gliosidosis B1 variant; Activation energy 285, 45 Respiratory arrest; Hypermagnesemia; Intoxica- tion; Tocolysis 285, 191 Myocardial ischemia/reperfusion; 8-Hydroxy- deoxyguanosine; Microdialysis; High-perfor- Selenium; Copper; Zinc; Potentiometric stripping mance liquid chromatography 285, 163 analysis; Constant current stripping analysis 285, 53 Non-small cell lung cancer; c-erbB-2 Expression; p53 Mutations; Flow cytometry; p53 Overex- Sialic acid; Hypercholesterolemia; Combined hy- pression; Epidermal growth factor receptor; Re- perlipidemia; LDL kinetics 285, 69 currence 285, 105 Tocolysis; Hypermagnesemia; Intoxication; Respi- p53 Mutations; Non-small! cell lung cancer; c- ratory arrest 285, 191 erbB-2 Expression; Flow cytometry; p53 Over- expression; Epidermal growth factor receptor; Tumor associated antigen; Papillary thyroid car- Recurrence 285, 105 cinoma 285, 131 p53 Overexpression; Non-small cell lung cancer; Type I hyperlipidemia; Lipoprotein lipese; Asn c-erbB-2 Expression; p53 Mutations; Flow cy- 291 285, 173 tometry; Epidermal growth factor receptor; Re- currence 285, 105 Type I hyperlipoproteinemia; Lipoprotein lipase deficiency; Hyperchylomicronemia; Compound Papillary thyroid carcinoma; Tumor associated heterozygous mutation; Hypertriglyceridemia; antigen 285, 131 Markit-F LPL 285, 143 Partial cDNA sequence; Adenylyl cyclases V and Umbilical cord blood; Placenta; Brush border VI; Human heart; Quantitative RT-PCR 285, membrane; Antioxidants; Lipid peroxidation 155 285, | Placenta; Brush border membrane; Umbilical cord Zinc; Copper; Selenium; Potentiometric stripping blood; Antioxidants; Lipid peroxidation 285, | analysis; Constant current stripping analysis 285, 53 Postburn; LD-Ig complex 285, 195 Potentiometric stripping analysis; Copper; Zinc; Selenium; Constant current stripping analysis 285, 53